When compared to the literature, the CDC27, KRAS, BRAF, BRAF, PTEN, PIK3CA, and BRCA2 mutations were determined at a higher rate and the APC mutation at a lower rate in the somatic mutation profile identified by the NGS system in patients with CRC in a specific region of the Turkish population. This evidence concerns the gene BRCA2 and colorectal carcinoma.